Standard Life Investments Higher In
|Bid Price||-||Offer Price||-|
|Mid Price||GBX 61.77||Day Change||GBX +0.02 (0.03%)|
|Price Date||28 Apr 2017||Crown Rating|
|Shares Class||Inc.||Yield||3.61 %|
|Total Expense Ratio||0.00||Fund Size||477,100,000.00|
|Launch Date||07/02/2000||Standard Initial Charge (%)||0.00|
|Annual Management Charge (%)||0.45||Sector||IMA UK Equity Income|
|Min Investment (£)||0.00||Total Expense Ratio (%)||0.00|
|ISIN||GB00BBX46H43||Min TopUp (£)||0.00|
The fund aims to provide a significantly higher level of income than that available on gilts by investing mainly in sterling and euro denominated sub-investment grade corporate bonds.
Fraser joined Standard Life Investments in 2011 and is an Investment Director in the Credit team. He is the Lead Manager of the Ignis High Income Fund and also has responsibility for companies specialising in the Healthcare and Pharmaceutical sectors across the full bond spectrum. Previously, Fraser spent four years at Lehman Brothers as analyst and industry specialist for the Healthcare, Pharmaceuticals, and Chemicals sectors. He also worked for Deloitte, Edinburgh as an Assistant Manager in Assurance & Advisory Department. Fraser has 12 years’ experience in the industry, is a CFA Charterholder, a Chartered Accountant (CA) and holds a PhD in synthetic organic chemistry from Heriot-Watt University.